Resources

The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies

Translational & Preclinical Development

Histology Services - MLM Medical Labs

Translational & Preclinical Development

Animal Health - MLM Medical Labs

Translational & Preclinical Development

Virology Studies with Maestro Z - Axion Biosystems

Translational & Preclinical Development

Biognosys Research Services

Translational & Preclinical Development

Developing Tumor Spheroid Protocol - CellLink

Translational & Preclinical Development

Anti-Idiotypic Antibody Production - Rockland

pre
Translational & Preclinical Development

Rockland Custom Services

Translational & Preclinical Development

Preclinical Strategies for Combination Immunotherapies

Oncology is almost always oriented towards simultaneous treatment options. We explore why as well as the approach’s unique challenges.
Translational & Preclinical Development

AAV Gene Therapy and CAR T Therapies: Immunogenicity and Immunoassay Development

Dr. Vibha Jawa, Executive Director, Nonclinical Disposition and Bioanalysis at BMS
Translational & Preclinical Development

Investigating the Core Tenet of Immunotherapy: MHC-I Peptide-Receptor Complexes

Axel Ducret, a Roche Senior Principal Scientist, takes us through his work on one of the most important cellular mechanisms in immunotherapy.
Translational & Preclinical Development

The Future of CAR T for Solid Tumours: Antigen Discovery, Persistence, and Fitness

CAR T, the rockstar therapy of immuno-oncology, finds its next big challenge in translating research for use in solid tumours.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things immuno